Terminal differentiation into adipocyte and growth inhibition by PPARγ activation in human A549 lung adenocarcinoma cells

References

• Becker KA, Stein JL, Lian JB, van Wijnen AJ, Stein GS. 2007. Establishment of histone gene regulation and cell cycle checkpoint control in human embryonic stem cells. J Cell Physiol. 210:517–526.
   PubMed Web of Science ®Google Scholar
• Bilic J, Izpisua Belmonte JC. 2012. Concise review: induced pluripotent stem cells versus embryonic stem cells: close enough or yet too far apart? Stem Cells. 30:33–41.
   PubMed Web of Science ®Google Scholar
• Blomen VA, Boonstra J. 2007. Cell fate determination during G1 phase progression. Cell Mol Life Sci. 64:3084–3104.
   PubMed Web of Science ®Google Scholar
• Bodles AM, Varma V, Yao-Borengasser A, Phanavanh B, Peterson CA, McGehee RE Jr, Rasouli N, Wabitsch M, Kern PA. 2006. Pioglitazone induces apoptosis of macrophages in human adipose tissue. J Lipid Res. 47:2080–2088.
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. 2018. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 68:394–424.
   PubMed Web of Science ®Google Scholar
• Buchbinder EI, Desai A. 2016. CTLA-4 and PD-1 pathways: similarities, differences, and implications of their inhibition. Am J Clin Oncol. 39:98–106.
   PubMed Web of Science ®Google Scholar
• Buxant F, Kindt N, Laurent G, Noël JC, Saussez S. 2015. Antiproliferative effect of dexamethasone in the MCF-7 breast cancer cell line. Mol Med Rep. 12:4051–4054.
   PubMed Web of Science ®Google Scholar
• Cho H, Lee YS, Kim J, Chung JY, Kim JH. 2013. Overexpression of glucose transporter-1 (GLUT-1) predicts poor prognosis in epithelial ovarian cancer. Cancer Invest. 31:607–615.
   PubMed Web of Science ®Google Scholar
• DeFronzo RA, Tripathy D, Schwenke DC, Banerji M, Bray GA, Buchanan TA, Clement SC, Henry RR, Hodis HN, Kitabchi AE, et al. 2011. Pioglitazone for diabetes prevention in impaired glucose tolerance. N Engl J Med. 364:1104–1115.
   PubMed Web of Science ®Google Scholar
• Elrod HA, Sun SY. 2008. PPAR gamma and apoptosis in cancer. PPAR Res. 2008:704165.
   PubMed Web of Science ®Google Scholar
• Fajas L, Debril MB, Auwerx J. 2001. Peroxisome proliferator-activated receptor-gamma: from adipogenesis to carcinogenesis. J Mol Endocrinol. 27:1–9.
   PubMed Web of Science ®Google Scholar
• Gatenby RA, Gillies RJ. 2004. Why do cancers have high aerobic glycolysis? Nat Rev Cancer. 4:891–899.
   PubMed Web of Science ®Google Scholar
• Hamanaka RB, Chandel NS. 2012. Targeting glucose metabolism for cancer therapy. J Exp Med. 209:211–215.
   PubMed Web of Science ®Google Scholar
• Hansson B, Morén B, Fryklund C, Vliex L, Wasserstrom S, Albinsson S, Berger K, Stenkula KG. 2019. Adipose cell size changes are associated with a drastic actin remodeling. Sci Rep. 9:12941.
   PubMed Web of Science ®Google Scholar
• He S, Nakada D, Morrison SJ. 2009. Mechanisms of stem cell self-renewal. Annu Rev Cell Dev Biol. 25:377–406.
   PubMed Web of Science ®Google Scholar
• Huang CY, Ju DT, Chang CF, Muralidhar Reddy P, Velmurugan BK. 2017. A review on the effects of current chemotherapy drugs and natural agents in treating non-small cell lung cancer. Biomedicine (Taipei). 7:23.
   PubMedGoogle Scholar
• Ilango S, Paital B, Jayachandran P, Padma PR, Nirmaladevi R. 2020. Epigenetic alterations in cancer. Front Biosci (Landmark Ed). 25:1058–1109.
   PubMed Web of Science ®Google Scholar
• Jeon BG, Jang SJ, Park JS, Subbarao RB, Jeong GJ, Park BW, Rho GJ. 2015. Differentiation potential of mesenchymal stem cells isolated from human dental tissues into non-mesodermal lineage. Anim Cell Syst. 19:321–331.
   Web of Science ®Google Scholar
• Kim HI, Moon SH, Lee WC, Lee HJ, Shivakumar SB, Lee SH, Park BW, Rho GJ, Jeon BG. 2018. Inhibition of cell growth by cellular differentiation into adipocyte-like cells in dexamethasone sensitive cancer cell lines. Anim Cells Syst. 22:178–188.
   PubMed Web of Science ®Google Scholar
• Kim YD, Jang SJ, Lim EJ, Ha JS, Shivakumar SB, Jeong GJ, Rho GJ, Jeon BG. 2017. Induction of telomere shortening and cellular apoptosis by sodium meta-arsenite in human cancer cell lines. Anim Cell Syst. 21:241–254.
   PubMed Web of Science ®Google Scholar
• Kudoh A, Satoh H, Hirai H, Watanabe T. 2011. Pioglitazone upregulates adiponectin receptor 2 in 3T3-L1 adipocytes. Life Sci. 88:1055–1062.
   PubMed Web of Science ®Google Scholar
• Lee CJ, Han JS, Seo CY, Park TH, Kwon HC, Jeong JS, Kim IH, Yun J, Bae YS, Kwak JY, Park JI. 2006. Pioglitazone, a synthetic ligand for PPAR gamma, induces apoptosis in RB-deficient human colorectal cancer cells. Apoptosis. 11:401–411.
   PubMed Web of Science ®Google Scholar
• Lefterova MI, Haakonsson AK, Lazar MA, Mandrup S. 2014. PPARγ and the global map of adipogenesis and beyond. Trends Endocrinol Metab. 25:293–302.
   PubMed Web of Science ®Google Scholar
• Mao J, Li X, Chen W, Xu B, Zhang H, Li H, Wang L, Jin X, Zhu J, Lin G, et al. 2012. Cell cycle-dependent subcellular distribution of ClC-3 in HeLa cells. Histochem Cell Biol. 137:763–776.
   PubMed Web of Science ®Google Scholar
• Prins JB, Niesler CU, Winterford CM, Bright NA, Siddle K, O’Rahilly S, Walker NI, Cameron DP. 1997. Tumor necrosis factor-alpha induces apoptosis of human adipose cells. Diabetes. 46:1939–1944.
   PubMed Web of Science ®Google Scholar
• Reichert M, Eick D. 1999. Analysis of cell cycle arrest in adipocyte differentiation. Oncogene. 18:459–466.
   PubMed Web of Science ®Google Scholar
• Sandouk T, Reda D, Hofmann C. 1993. Antidiabetic agent pioglitazone enhances adipocyte differentiation of 3T3-F442A cells. Am J Physiol. 264(6 Pt 1):C1600-8.
   PubMedGoogle Scholar
• Saretzki G. 2018. Telomeres, telomerase and ageing. Subcell Biochem. 90:221–308.
   PubMedGoogle Scholar
• Schirrmacher V. 2019. From chemotherapy to biological therapy: a review of novel concepts to reduce the side effects of systemic cancer treatment (review). Int J Oncol. 54(2):407–419.
   PubMed Web of Science ®Google Scholar
• Shaw RJ. 2006. Glucose metabolism and cancer. Curr Opin Cell Biol. 18:598–608.
   PubMed Web of Science ®Google Scholar
• Takahashi N, Okumura T, Motomura W, Fujimoto Y, Kawabata I, Kohgo Y. 1999. Activation of PPAR gamma inhibits cell growth and induces apoptosis in human gastric cancer cells. FEBS Lett. 455:135–139.
   PubMed Web of Science ®Google Scholar
• Zhou W, Yang P, Liu L, Zheng S, Zeng Q, Liang H, Zhu Y, Zhang Z, Wang J, Yin B, et al. 2015. Transmembrane tumor necrosis factor-alpha sensitizes adipocytes to insulin. Mol Cell Endocrinol. 406:78–86.
   PubMed Web of Science ®Google Scholar